BAX - Baxter Non-GAAP EPS of $0.65 beats by $0.04 revenue of $3.59B beats by $40M
2024-05-02 07:19:27 ET
More on Baxter
- Baxter International Inc. Is A Buy (Technical Analysis)
- Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
- Baxter: Market-Leading Medical Supplier With Lots In The Pipeline
- Baxter Q1 2024 Earnings Preview
- Baxter expands portfolio with new injectable products in U.S.